GleamWall
中文EN

COLL COLLEGIUM PHARMACEUTICAL, INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1267565 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.7%
TTM net income YoY-34.7%
TTM EPS YoY-37.9%
Revenue 3-yr CAGR14.2%
Net income 3-yr CAGR61.8%

Margins

Gross margin59.0%
Operating margin15.2%
Net margin4.7%
FCF margin41.3%
EBITDA margin15.7%

Returns

ROE13.4%
ROA2.1%
ROIC (approx.)81.3%
Asset turnover0.44x

Leverage & solvency

Liabilities / assets85.9%
Debt / equity0.00x
Current ratio1.01x
Interest coverage1.62x

Cash quality & payout

Operating cash flow / net income8.86x
Accruals ratio-16.2%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$780.57M$631.45M
Cost of revenue$317.31M$254.10M
Gross profit$463.26M$377.34M
R&D expense—$0
SG&A expense$284.80M$210.36M
Operating income$179.64M$169.90M
Interest expense$82.31M$73.97M
Pretax income$92.62M$98.57M
Income tax$29.75M$29.38M
Net income$62.87M$69.19M
EBITDA$183.82M$173.75M
EPS (basic)1.982.14
EPS (diluted)1.731.86
Weighted avg. shares (diluted)39.70M40.42M
Balance sheet
Cash & equivalents$231.25M$96.61M
Short-term investments$155.43M$92.20M
Receivables$211.33M$228.54M
Inventory$40.91M$35.56M
Current assets$691.41M$482.26M
PP&E, net$12.01M$14.33M
Goodwill$145.93M$162.33M
Intangibles$669.51M$891.40M
Total assets$1.66B$1.66B
Current liabilities$440.03M$509.51M
Total liabilities$1.36B$1.43B
Shareholders' equity$301.68M$228.84M
Shares outstanding31.71M31.44M
Cash flow statement
Operating cash flow$329.32M$204.98M
Capital expenditure$1.74M$1.65M
Free cash flow$327.58M$203.33M
Investing cash flow-$63.53M-$287.76M
Financing cash flow-$110.25M-$60.60M
Depreciation & amortization$4.18M$3.86M
Stock-based compensation$41.91M$32.40M
Share buybacks$25.10M$60.02M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.